The diagnostic and prognostic significance of ANCA

Renal Failure

Volumn 18, Issue 5, 1996, Pages 803-812

  Lesavre, Philippe ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; CHURG STRAUSS SYNDROME; CONFERENCE PAPER; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0029956756     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229609047708     Document Type: Conference Paper

References (48)

1. Davies DJ, Morgan JE, Nyall JF, Ryan GB: Segmental necrotizing glomerulonephritis with antineutrophil antibodies: possible arbovirus aetiology? Br Med J 285:606-612, 1982.
2. Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis, N Engl J Med 318:1651-1657, 1988.
3. Cameron JS: New horizons in renal vasculitis. Klin Wochenschr 69:536-551, 1991.
4. Cohen Tervaert JW, Mulder L, Stegeman C, Elema J, Huitema M, The H, Kallenberg C: Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 52:115-120, 1993.
5. Lesavre P, Noel LH, Chauveau D, Geffriaud C, Grünfeld JP: Antigen specificities and clinical distribution of ANCA in kidney diseases. Klin Wochenschr 69.552-557, 1991.
6. Lesavre P: Antineutrophil cytoplasmic autoantibodies antigen specificity. Am J Kidney Dis 18:159-163, 1991.
7. Gross WL, Csernok E, Helmchen U: Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis. APMIS 103:81-97, 1995.
8. Hagen EC, Ballieux BE, van Es LA, Daha MR, van der Woude, FJ: Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood 81:1996-2002, 1993.
9. Gaskin G, Turner AN, Ryan JJ, Rees AJ, Pusey CD: Significance of autoantibodies to purified proteinase 3 in systemic vasculitis. Adv Exp Med Biol 336:287-289, 1993
10. Cohen Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, Kallenberg CG: Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336:709-711, 1990.
11. Gaskin G, Savage CO, Ryan JJ, Jones S, Rees AJ, Lockwood CM, Pusey CD: Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 6:689-694, 1991.
12. Pettersson E, Heigl, Z: Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study. Clin Nephrol 37:219-228, 1992.
13. Jayne DRW, Gaskin G, Pusey CD, Lockwood, CM: ANCA and predicting relapse in systemic vasculitis. Q J Med 88:127-133, 1995.
14. Goldschmeding R, van der School CE, ten Bokkel Huinink D, Hack CE, van den Ende ME, Kallenberg CG, von dem Borne AE: Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophospatebinding protein in the lysosomes of normal human neutrophils. J Clin Invest 84:1577-1587, 1989.
15. Lüdemann J, Utecht B, Gross WL: Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme, J Exp Med 171:357-362, 1990.
16. Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, The TH, von dem Borne AE, Kallenberg CG: Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 37:799-806, 1990.
17. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL: Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 95:244-250, 1994.
18. Niles JL, McCluskey RT, Ahmad MF, Arnaout MA: Wegener's granulomatosis autoantigen is a novel serine proteinase. Blood 74:1888-1893, 1989.
19. Baslund B, Petersen J, Permin H, Wiik A, Wieslander J: Measurements of proteinese 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. Immunol Methods 175:215-225, 1994.
20. Esnault VL, Testa A, Audrain M, Roge C, Hamidou M, Barrier JH, Sesboue R, Martin JP, Lesavre P: Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 43:1329-1332, 1993.
21. Segelmark M, Elzouki AN, Wieslander J, Enksson S: The PiZ gene of alpha(1)-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 48:844-850, 1995.
22. Zhao MH, Jones SJ, Lockwood CM: Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 99:49-56, 1995.
23. Nassberger L, Sjoholm AG, Bygren P, Thysell H, Hojer-Madsen M, Rasmussen N: Circulating antineutrophil cytoplasm antibodies in patients with rapidly progressive glomerulonephritis and extracapillary proliferation. J Intern Med 225:191-196, 1989.
24. Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A: Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 124:986-988, 1994.
25. Dolman KM, Gans RO, Vervaat TJ, Zevenbergen G, Maingay D, Nikkels RE, Donker AJ, von dem Borne AE, Goldschmeding R: Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 342:651-652, 1993.
26. Dolman KM, Goldschmeding R, Sonnenberg A, von dem Borne AE: ANCA related antigens. APMIS 19(suppl):28, 1990.
27. Lesavre P, Noël LH, Gayno S, Nusbaum P, Reumaux D, Erlinger S, Grünfeld JP, Halbwachs-Mecarelli, L: Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations. J Auto immun 6:185-195, 1993.
28. Halbwachs-Mecarelli L, Nusbaum P, Noël LH, Reumaux D, Erlinger S, Grunfeld JP, Lesavre P: Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 90:79-84, 1992.
29. Dolman KM, Damsma I, Tool AT, Sonnenberg A, von dem Borne AE, Goldschmeding R: A novel specificity of anticytoplasmic autoantibodies directed against eosinophil peroxidase. Clin Exp Immunol 92:58-64, 1993.
30. Kallenberg CG, Brouwer E, Weening JJ, Tervaert JW: Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 46:1-15, 1994.
31. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies to neutrophils and monocytes : a new tool for diagnosis and a marker of disease activity in Wegener's granulomatosis. Lancet ii:425-429, 1985.
32. Geffriaud-Ricouard C, Noël LH, Chauveau D, Houhou S, Grünfeld, JP, Lesavre P: Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 39:125-136, 1993.
33. Guillevin L, Visser H, Noel LH, Pourrat J, Vernier I, Gayraud M, Oksman F, Lesavre P: Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome-62 patients. J Rheumatol 20:1345-1349, 1993.
34. Noël LH, Geffnaud C, Chauveau D, Houhou S, Landais P, Kirhaoui F, Nusbaum P, Gouarin C, O'Donoghue D, Halbwachs-Mecarelli L, Grünfeld JP, Lesavre P: Antineutrophil cytoplasm antibodies' diversity and clinical applications. In Advances in Nephrology. Chicago, Year Book Medical Publishers, 1993, pp 237-267.
35. O'Donoghue DJ, Nusbaum P, Noel LH, Halbwachs-Mecarelli L, Lesavre P: Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schonlein purpura. Nephrol Dial Transplant 7:534-538, 1992.
36. Jayne DR, Marshall PD, Jones SJ, Lockwood CM: Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 37:965-970, 1990.
37. Duerr RH, Neigut DA: Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup [see comments]. Gastroenterology 108:423-427, 1995.
38. Reumaux D, Colombel JF, Duclos B, Chaussade S, Belaiche J, Jacquot S, Dupas JL, Molis C, Duthilleul P: Antineutrophil cytoplasmic autoantibodies in sera from patients with ulcerative colitis after proctocolectomy with ileo-anal anastomosis. Adv Exp Med Biol 336:523-525, 1993.
39. Targan SR, Landers CJ, King NW, Podolsky DJ, Shanahan F: Ulcerative colitis-linked antineutrophil cytoplasmic antibody in the cotton-top tamarin model of colitis Gastroenterology 102:1493-1498, 1992.
40. Peen E, Aimer S, Bodemar G, Ryden BO, Sjolin C, Tejle K, Skogh T: Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut 34:56-62, 1993.
41. Seibold F, Slametschka D, Gregor M, Weber P: Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis [see comments]. Gastroenterology 107:532-536, 1994
42. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH: Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 33:657-662, 1992.
43. Snook JA, Chapman RW, Fleming K, Jewell DP: Anti-neutrophil nuclear antibodies in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 76:30-33, 1989.
44. Duerr RH, Targan SR, Landers CJ, Larusso NF, Lindsay KL, Wiesner RH, Shanahan F: Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 100:1835-1891, 1991.
45. Klaassen RJ, Goldschmeding R, Dolman KM, Vlekke AB, Weigel HM, Eeftinck Schattenkerk JK, Mulder JW, Westedt ML, von dem Borne AE: Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol 87:24-30, 1992.
46. Falk RJ, Hogan S, Carey TS, Jennette JC: Clinical course of anti-neutrophil cytoplasmic autoantibodyassociated glomerulonephritis and systemic vasculitis. Ann Intern Med 113:656-663, 1990.
47. MacIsaac AI, Moran JE, Davies DJ, Murphy BF, Georgiou T, Niall JF: Antineutrophil cytoplasm antibody (ANCA) associated vasculitis. Clin Nephrol 34:5-8, 1990.
48. Cohen P, Guillevin L, Baril L, Lhote F, Noel LH, Lesavre P: Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients. Clin Exp Rheumatol 13:193-198, 1995.